Key result
Melatonin reduced the incidence of reperfusion arrhythmias from 100% in control hearts to 30-50% in treated hearts, likely due to its antioxidant effects and lengthening of action potential duration.
Why the study?
Does melatonin reduce ischemia/reperfusion-induced arrhythmias in isolated rat hearts?
Does melatonin reduce ischemia/reperfusion-induced arrhythmias in isolated rat hearts?
Absolute Event Rate: 30% vs 100%
Melatonin reduces ischemia/reperfusion-induced arrhythmias in isolated rat hearts, likely due to antioxidant effects and lengthening of action potential duration at higher concentrations.
Caution against clinical use of melatonin for reperfusion arrhythmias; leaves open translation from isolated rat hearts to human trials.
Reperfusion after a short period of cardiac ischemia triggers ventricular arrhythmias attributable to ionic imbalance and oxidative stress. Melatonin offers some degree of protection, but its effects on the cardiac action potentials are unknown. We evaluated the effects of 5, 10, 20 and 50 microM melatonin in isolated perfused rat hearts subjected to 10 min of regional ischemia. ECG and membrane potentials were synchronously displayed. After 15 min of reperfusion, total antioxidant capacity (TAC) was determined. Melatonin did not change the ischemic depolarization nor the action potential amplitude depression, but at the end of ischemia the action potential duration (APD) decreased in control and 5 microM melatonin-treated hearts. By contrast, it returned to preischemic levels in hearts given 20 and 50 microM melatonin. Melatonin reduced the incidence of reperfusion arrhythmias from 100% in control to 50% in 5 and 10 microM, to 40% in 20 microM and 30% in 50 microM hearts. TAC values were higher at all melatonin concentrations. We conclude that melatonin reduced the incidence of reperfusion arrhythmias because of its antioxidant effects. In addition, at 20 and 50 microM lengthened APD and promoted an improved protection. This latter effect should be considered when in vivo applications of melatonin are considered.
No takes yet. Share an insight, caveat, or question.
Diez et al. (2009) studied Ischemia/reperfusion-induced arrhythmias. Melatonin vs. Control was evaluated on Incidence of reperfusion arrhythmias. Melatonin reduced the incidence of reperfusion arrhythmias from 100% in control hearts to 30-50% in treated hearts, likely due to its antioxidant effects and lengthening of action potential duration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: